AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 238.90B |
| Enterprise Value | 265.36B |
| Trailing P/E | 37.61 |
| Forward P/E | 16.53 |
| PEG Ratio (5 yr expected) | 0.86 |
| Price/Sales (ttm) | 4.93 |
| Price/Book (mrq) | 6.08 |
| Enterprise Value/Revenue | 5.40 |
| Enterprise Value/EBITDA | 18.84 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.17 |
| 52-Week Change 3 | 15.56% |
| S&P500 52-Week Change 3 | 32.65% |
| 52 Week High 3 | 87.68 |
| 52 Week Low 3 | 60.47 |
| 50-Day Moving Average 3 | 81.43 |
| 200-Day Moving Average 3 | 73.95 |
Share Statistics
| Avg Vol (3 month) 3 | 4.58M |
| Avg Vol (10 day) 3 | 4.26M |
| Shares Outstanding 5 | 3.1B |
| Implied Shares Outstanding 6 | 3.18B |
| Float 8 | 1.54B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 17.03% |
| Shares Short (Sept 13, 2024) 4 | 6.45M |
| Short Ratio (Sept 13, 2024) 4 | 1.87 |
| Short % of Float (Sept 13, 2024) 4 | N/A |
| Short % of Shares Outstanding (Sept 13, 2024) 4 | 0.21% |
| Shares Short (prior month Aug 15, 2024) 4 | 8.51M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 1.49 |
| Forward Annual Dividend Yield 4 | 1.92% |
| Trailing Annual Dividend Rate 3 | 2.97 |
| Trailing Annual Dividend Yield 3 | 3.81% |
| 5 Year Average Dividend Yield 4 | 2.37 |
| Payout Ratio 4 | 70.39% |
| Dividend Date 3 | Sept 09, 2024 |
| Ex-Dividend Date 4 | Aug 09, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jul 27, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 13.11% |
| Operating Margin (ttm) | 22.42% |
Management Effectiveness
| Return on Assets (ttm) | 7.68% |
| Return on Equity (ttm) | 16.74% |
Income Statement
| Revenue (ttm) | 49.13B |
| Revenue Per Share (ttm) | 2.63 |
| Quarterly Revenue Growth (yoy) | 13.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 16.97B |
| Net Income Avi to Common (ttm) | 6.44B |
| Diluted EPS (ttm) | 2.06 |
| Quarterly Earnings Growth (yoy) | 6.00% |
Balance Sheet
| Total Cash (mrq) | 7.08B |
| Total Cash Per Share (mrq) | 4.57 |
| Total Debt (mrq) | 33.65B |
| Total Debt/Equity (mrq) | 84.97% |
| Current Ratio (mrq) | 0.89 |
| Book Value Per Share (mrq) | 25.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.06B |
| Levered Free Cash Flow (ttm) | 9.82B |
© 2024 Yahoo. All rights reserved.